Leave Your Message

Submit An Free Inquiry

Our medical team will make an evaluation for you, based on the information you provided. This procedure is free of charge.

AI Helps Write
AI Helps Write

Ọrịa kansa ọbara Lymphoblastic dị oke njọ (T-ALL)-10

Onye Ọrịa: Yangyang

Okike:Nwoke

Afọ: afọ 13

Mba: Ndị Chaịna

Nchọpụta ọrịaỌrịa Leukemia Lymphoblastic Dị Akpịrị (T-ALL)

    Otu nwa nwoke dị afọ iri na atọ aha ya bụ Yangyang si Panzhihua, Sichuan Province, mere CAR-T wee jiri akwanye ya n'ime akpa ahụ.


    Na mbụ, Yangyang pụtara "ọnyá gbasasịrị n'ahụ ya niile, ya na ike ọgwụgwụ" na Eprel 12, 2021. A chọpụtara na ọ nwere ọrịa leukemia lymphoblastic (ụdị T-cell) nke nwere ọbara ọgbụgba n'ime ụbụrụ na ọrịa akpa ume nke a chọpụtara site na nyocha MICM nke ụmị ọkpụkpụ n'ụlọ ọgwụ buru ibu na Chongqing. O mere usoro ọgwụgwọ chemotherapy ugboro atọ n'ụlọ ọgwụ ọzọ, mana ụmị ọkpụkpụ azaghị. Ka ọ na-erule mmalite ọnwa Juun, ọ malitere inwe adịghị ike n'akụkụ abụọ nke ahụ ya ma ghara ịga ije.


    Na Julaị 1, 2021, a nabatara Yangyang na Ngalaba Hematology Ward nke 2 anyị. O debanyere aha na nnwale ahụike CD7 CAR-T na Julaị 8 ma natara ọgwụ mkpụrụ ndụ CD7 CAR-T onwe ya na Julaị 26 maka ọgwụgwọ immunotherapy. Ụbọchị iri na isii ka e tinyere ọgwụ ahụ, ọdịdị ọkpụkpụ gosiri na ọ gbapụrụ, ebe cytometry flow gosiri na ọ nwere 0.07% nke T lymphoblasts na-adịghị ike. Mgbe e nyere ya ọgwụgwọ anụ ahụ, ọ laghachiri n'ike ije n'onwe ya. Ka ọ na-erule ụbọchị 31 mgbe e tinyere ya ọgwụ ahụ, ọkpụkpụ ya gbapụrụ kpamkpam.


    Ugbu a, a kpọfere Yangyang na Ngalaba nke Isii nke Ngalaba Mgbanwe Ọkpụkpụ maka ọgwụgwọ ọzọ. Dr. Hai si Ngalaba nke Isii kwuru na Yangyang anọwo na-arụkọ ọrụ ma na-enwe olileanya n'oge ọgwụgwọ ya. O mere mgbanwe mkpụrụ ndụ hematopoietic (site n'aka nna ya) na Septemba 28. A nabatara ọnọdụ ndị ọrụ ibe Ngalaba Hematology mepụtara maka mgbanwe eriri ya nke ọma.


    Ndị ọrịa a, tupu ha abanye na nnwale ahụike CD7 CAR-T, gosipụtara ọtụtụ ihe mgbaàmà dịka nlọghachi azụ mgbe a mịnyechara ha ihe, ngosipụta abụọ nke T/myeloid, ọrịa leukemia T-cell acute refractory/resisted, ọrịa leukemia sistemụ akwara etiti, ọbara ọgbụgba n'ime ụbụrụ, na ọrịa akpa ume. Mgbe a nyochachara ma gwọọ ya site na ọgwụgwọ CD7 CAR-T, ha niile nwetara mgbaghara zuru oke, na-emezu ihe a tụrụ anya ya.


    Ebe anyị na-ahụ maka ọgwụgwọ CAR-T emeela nnyocha nke ọma n'ihe gbasara ọgwụgwọ CAR-T ma nweta ahụmịhe bara ụba n'ịchịkwa CRS. Maka ọtụtụ ndị sonyere, ihe kacha njọ bụ oke ahụ ọkụ. "Enwere m ike iwepụ ya kpamkpam, yabụ ahụ ọkụ abụghị ihe ọ bụla! Achọrọ m ka ọtụtụ mmadụ mara na BIOOCUS nwere ike ime CAR-T!" ka Yangyang si Fujian kwuru mgbe a tọhapụrụ ya.

    nkọwa2

    Submit An Free Inquiry

    Our medical team will make an evaluation for you, based on the information you provided. This procedure is free of charge.

    AI Helps Write